The U.S. Preventive Services Task Force yesterday issued a draft recommendation that clinicians offer pre-exposure prophylaxis (PrEP), a daily pill that helps prevent HIV, to people at high risk for HIV. The task force also continued to recommend that clinicians screen all Americans aged 15 to 65 and pregnant women for HIV, as well as younger adolescents and older adults at increased risk for the virus. The panel will accept comments on the draft recommendations through Dec. 26.

Related News Articles

Chairperson's File
June 5 is the fourth annual Hospitals Against Violence Hope (#HAVhope) Friday. This year’s national day of awareness, which is taking place as protests against…
Headline
During Community Health Improvement Week, the AHA is sharing stories, resources, tools and leadership blogs that reflect on the importance of community and…
Headline
Today marks the first day of Mental Health Awareness Month, an important topic especially during the COVID-19 pandemic. Brent Forester, M.D., chief of the…
Blog
The AHA is committed to ensuring that all people, regardless of background or zip code, have equitable access to quality health care. As the COVID-19 pandemic…
Headline
The first AHA Age-Friendly Health Systems action community concluded this month, with 184 health care teams and 12 allied associations across the U.S.…
Headline
The Government Accountability Office today recommended certain actions to enhance federal efforts to monitor and address antibiotic resistance. Among other…